KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS
Pharmaceutical company · 114 brands · 134 molecules
Ranked #7 of 39 companies in Beta-Lactam Antibacterials, Penicillins
Company overview
KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 114 product registrations across 134 distinct molecules. It is the 149th largest registrant in Pakistan by product count, and ranks 7th of 39 in Beta-Lactam Antibacterials, Penicillins. Its portfolio is concentrated in Beta-Lactam Antibacterials, Penicillins and Antiinflammatory And Antirheumatic Products. DRAP has issued 1 alert involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by KRKA-PAK
46 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
Price ceiling age
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
1 alert in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for KRKA-PAK
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included